regavirumab
cytomegaloviremia
cytoplasmic polyhedrosis virus
sevirumab
cyanomyovirus
cystovirus
cyanopodovirus
libivirumab
immunovirus
gancyclovir
intetumumab
amlitelimab
cyclovirus
cilgavimab
suvizumab
bavituximab
carlumab
maribavir
palivizumab
ansuvimab
aquabirnavirus
cytomegaly
tixagevimab
olendalizumab
pancytokeratin
glembatumumab
heterophil antibody
cypovirus
neoantigen
polyvaccine
heterophile antibody
cytomegalovirus
Forssman antibody
immunocytofluorometry
zanolimumab
microantibody
clenoliximab
scytovirin
soravtansine
evolocumab
ipilimumab
HIV
phage
vaccinia
antinucleosome
multinucleopolyhedrovirus
avdoralimab
DNAemia
acute retroviral syndrome
ozoralizumab